𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The cardiovascular risk marker asymmetrical dimethylarginine is not affected by venous thromboembolism

✍ Scribed by Dominik G. Haider; Robert A. Bucek; Markus Reiter; Erich Minar; Gregor Hron; Paul A. Kyrle; Friedrich Mittermayer; Michael Wolzt

Book ID
119317730
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
90 KB
Volume
148
Category
Article
ISSN
1931-5244

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of comorbidity on risk of venous
Effect of comorbidity on risk of venous thromboembolism in patients with renal cell carcinoma11The project described was supported by the National Center for Research Resources, United States, through Grant KL2TR000084 the National Center for Advancing Translational Sciences, United States, through Grant KL2TR000084 and the National Institutes of Health, United States, through Grant KL2TR000084, and a grant from the Danish Cancer Society (R73-A4284-13-S17) and from the Karen Elise Jensen Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH and the Clinical Epidemiological Research Foundation.
✍ Smith, Angela B.; Horvath-Puhó, Erzsébet; Nielsen, Matthew E.; Lash, Timothy L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 220 KB